Source:http://linkedlifedata.com/resource/pubmed/id/15821340
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-4-20
|
pubmed:abstractText |
The aim of the present study is to clarify the mechanism for the decrease in intraocular pressure by 2-alkynyladenosine derivatives in rabbits. The receptor binding analysis revealed that 2-(1-octyn-1-yl)adenosine (2-O-Ado) and 2-(6-cyano-1-hexyn-1-yl)adenosine (2-CN-Ado) selectively bound to the A(2a) receptor with a high affinity. Ocular hypotensive responses to 2-O-Ado and 2-CN-Ado were inhibited by the adenosine A(2a)-receptor antagonist 1,3,7-trimethyl-8-(3-chlorostyryl)xanthine (CSC), but not by the adenosine A(1)-receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) or the adenosine A(2b)-receptor antagonist alloxazine. In addition, 2-O-Ado and 2-CN-Ado caused an increase in outflow facility, which was inhibited by CSC, but not by DPCPX or alloxazine. Moreover, 2-O-Ado and 2-CN-Ado increased cAMP in the aqueous humor, and the 2-O-Ado-induced an increase in cAMP was inhibited by CSC. These results suggest that 2-O-Ado and 2-CN-Ado reduced intraocular pressure via an increase in outflow facility. The ocular hypotension may be mainly mediated through the activation of adenosine A(2a) receptor, although a possible involvement of adenosine A(1) receptor cannot be completely ruled out. 2-O-Ado and 2-CN-Ado are useful lead compounds for the treatment of glaucoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Alkynes,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Adenosine A2A,
http://linkedlifedata.com/resource/pubmed/chemical/YT 146
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1347-8613
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
501-9
|
pubmed:meshHeading |
pubmed-meshheading:15821340-Adenosine,
pubmed-meshheading:15821340-Alkynes,
pubmed-meshheading:15821340-Animals,
pubmed-meshheading:15821340-Aqueous Humor,
pubmed-meshheading:15821340-Cyclic AMP,
pubmed-meshheading:15821340-Glaucoma,
pubmed-meshheading:15821340-Humans,
pubmed-meshheading:15821340-Intraocular Pressure,
pubmed-meshheading:15821340-Kinetics,
pubmed-meshheading:15821340-Male,
pubmed-meshheading:15821340-Rabbits,
pubmed-meshheading:15821340-Receptor, Adenosine A2A
|
pubmed:year |
2005
|
pubmed:articleTitle |
Involvement of adenosine A2a receptor in intraocular pressure decrease induced by 2-(1-octyn-1-yl)adenosine or 2-(6-cyano-1-hexyn-1-yl)adenosine.
|
pubmed:affiliation |
Drug Research Section II, Fukushima Research Laboratories, Toa Eiyo Ltd., Iizaka, Fukushima, Japan. konno.takashi@toaeiyo.co.jp
|
pubmed:publicationType |
Journal Article
|